Amanda Pereira-Salgado

Health Economic Evidence for Liquid- and Tissue-based Molecular Tests that Inform Decisions on Prostate Biopsies and Treatment of Localised Prostate Cancer: A Systematic Review

Koen Degeling, Amanda Pereira-Salgado, Niall M Corcoran, Paul C Boutros, Peter Kuhn, Maarten J IJzerman

Journal article  |  2021  |  European Urology Open Science

Context: Several liquid- and tissue-based biomarker tests (LTBTs) are available to inform the need for prostate biopsies and treat..

Do assumptions in health economic evaluations hamper drug uptake?

Fanny Franchini, Koen Degeling, Amanda Pereira-Salgado, Ben Tran, George Au-Yeung, Grant A McArthur, Belinda Lee, Benjamin J Solomon, Peter Gibbs, Maarten J IJzerman

Conference Proceedings  |  2020  |  Journal of Clinical Oncology

e19289 Background: Health economic studies of anti-cancer systemic treatments typically make strong assumptions regarding the num..

Health economic analysis of doublet chemotherapy with and without bevacizumab for first-line treatment of RAS mutant metastatic colorectal cancer based on real-world data.

Koen Degeling, Hui-Li Wong, Amanda Pereira-Salgado, Suzanne Kosmider, Rachel Wong, Jeanne Tie, Greg Stefanou, Louise M Nott, Jeremy David Shapiro, Gary Edward Richardson, Peter Gibbs, Maarten J IJzerman

Conference Proceedings  |  2020  |  Journal of Clinical Oncology

e16048 Background: Bevacizumab remains the dominant biologic treatment option for RAS mutant (RASmt) metastatic colorectal cancer..

Systematic Review of Efficacy and Health Economic Implications of Real-world Treatment Sequencing in Prostate Cancer: Where Do the Newer Agents Enzalutamide and Abiraterone Fit in?

Amanda Pereira-Salgado, Edmond Michael Kwan, Ben Tran, Peter Gibbs, Johann De Bono, Maarten IJzerman

Journal article  |  2020  |  European Urology Focus

CONTEXT: Optimal treatment sequencing of abiraterone and enzalutamide in chemotherapy-naïve metastatic castration-resistant prosta..

REAL-WORLD TREATMENT SEQUENCING OF ABIRATERONE AND ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC): WHAT ARE THE HEALTH ECONOMIC IMPLICATIONS?

A Pereira-Salgado, B Tran, E Kwan, A Angelyn, P Gibbs, MJ IJzerman

Conference Proceedings  |  2019  |  Value in Health

Advance Care Planning Simulation-Based Learning for Nurses: Mixed Methods Pilot Study

Amanda Pereira-Salgado, Steve Philpot, Jo Schlieff, Lisa O'Driscoll, Amber Mills

Journal article  |  2019  |  Clinical Simulation in Nursing

Background: Simulation-based learning (SBL) is beneficial for training health care professionals in advance care planning (ACP) or..

A Website Supporting Sensitive Religious and Cultural Advance Care Planning (ACPTalk): Formative and Summative Evaluation

Amanda Pereira-Salgado, Patrick Mader, Clare O'Callaghan, Leanne Boyd

Journal article  |  2018  |  JMIR Research Protocols

BACKGROUND: Advance care planning (ACP) promotes conversations about future health care needs, enacted if a person is incapable of..

Advance care planning, culture and religion: an environmental scan of Australian-based online resources

Amanda Pereira-Salgado, Patrick Mader, Leanne M Boyd

Journal article  |  2018  |  Australian Health Review

Objectives Culture and religion are important in advance care planning (ACP), yet it is not well understood how this is represente..

Religious leaders' perceptions of advance care planning: a secondary analysis of interviews with Buddhist, Christian, Hindu, Islamic, Jewish, Sikh and Baha'i leaders

Amanda Pereira-Salgado, Patrick Mader, Clare O'Callaghan, Leanne Boyd, Margaret Staples

Journal article  |  2017  |  BMC Palliative Care

BACKGROUND: International guidance for advance care planning (ACP) supports the integration of spiritual and religious aspects of ..

Mobile Health Intervention to Increase Oral Cancer Therapy Adherence in Patients With Chronic Myeloid Leukemia (The REMIND System): Clinical Feasibility and Acceptability Assessment

Amanda Pereira-Salgado, Jennifer A Westwood, Lahiru Russell, Anna Ugalde, Bronwen Ortlepp, John F Seymour, Phyllis Butow, Lawrence Cavedon, Kevin Ong, Sanchia Aranda, Sibilah Breen, Suzanne Kirsa, Andrew Dunlevie, Penelope Schofield

Journal article  |  2017  |  JMIR mHealth and uHealth

BACKGROUND: Optimal dosing of oral tyrosine kinase inhibitor therapy is critical to treatment success and survival of patients wit..